Loading
Search
▼ Nippon Life's Stable Business To Continue To Support Core Operating Profit
- Category:Other
The new-sales performance of Nippon Life Insurance Company (Nissay) is likely to be affected negatively over the near term by the COVID-19 pandemic and the low foreign interest rate environment, says AM Best.
Nevertheless, the global credit rating agency expects that the company’s stable in-force book of business will continue to support its core operating profit sustainably.
Indeed, Nissay’s operating performance has been strong and consistent, supported by a stable trend of premium income and core operating profit in the past. Annualised premiums from new policies declined over the first quarter of fiscal-year 2020 (April to June 2020), during which Japan declared a state of emergency, although this quickly recovered to 75% of the pre-pandemic level in the second quarter.
AM Best has affirmed Nissay's Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “aa-”. Concurrently, AM Best has affirmed the FSR of A- (Excellent) and the Long-Term ICR of “a-” of Nippon Life Insurance Company of America (dba Nippon Life Benefits or NLB) (West Des Moines, Iowa, USA). The outlook of these credit ratings is stable.
Balance sheet strength
The ratings of Nissay reflect its balance sheet strength, which AM Best categorises as strongest, as well as its strong operating performance, favourable business profile and appropriate enterprise risk management (ERM).
Nissay’s balance sheet strength assessment mainly reflects its risk-adjusted capitalisation at the strongest level, as measured by Best’s Capital Adequacy Ratio (BCAR). This assessment also is supported by the company’s low financial leverage, with an adjusted debt leverage ratio well below 25%.
In addition, its strong business network and good reputation as a life insurance company in Japan and overseas allow it to have good access to debt markets.
Business profile
Nissay is one of the leading life insurance companies in Japan, with a market share of 19% in terms of premium income. The company continues to have a strong sales representative base and is making efforts to diversify its distribution channels further to achieve greater revenue growth in its domestic market.
The company continues to be diversified modestly in terms of geography, given its relatively small operations in other Asia Pacific countries and the US.
The stable outlooks reflect AM Best’s expectation that Nissay will maintain its overall balance sheet assessment, supported by its risk-adjusted capitalisation at the strongest level, as measured by BCAR.
Ongoing strategic initiatives by management also are expected to ensure Nissay maintains a stable operating performance over the intermediate term.
Nevertheless, the global credit rating agency expects that the company’s stable in-force book of business will continue to support its core operating profit sustainably.
Indeed, Nissay’s operating performance has been strong and consistent, supported by a stable trend of premium income and core operating profit in the past. Annualised premiums from new policies declined over the first quarter of fiscal-year 2020 (April to June 2020), during which Japan declared a state of emergency, although this quickly recovered to 75% of the pre-pandemic level in the second quarter.
AM Best has affirmed Nissay's Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “aa-”. Concurrently, AM Best has affirmed the FSR of A- (Excellent) and the Long-Term ICR of “a-” of Nippon Life Insurance Company of America (dba Nippon Life Benefits or NLB) (West Des Moines, Iowa, USA). The outlook of these credit ratings is stable.
Balance sheet strength
The ratings of Nissay reflect its balance sheet strength, which AM Best categorises as strongest, as well as its strong operating performance, favourable business profile and appropriate enterprise risk management (ERM).
Nissay’s balance sheet strength assessment mainly reflects its risk-adjusted capitalisation at the strongest level, as measured by Best’s Capital Adequacy Ratio (BCAR). This assessment also is supported by the company’s low financial leverage, with an adjusted debt leverage ratio well below 25%.
In addition, its strong business network and good reputation as a life insurance company in Japan and overseas allow it to have good access to debt markets.
Business profile
Nissay is one of the leading life insurance companies in Japan, with a market share of 19% in terms of premium income. The company continues to have a strong sales representative base and is making efforts to diversify its distribution channels further to achieve greater revenue growth in its domestic market.
The company continues to be diversified modestly in terms of geography, given its relatively small operations in other Asia Pacific countries and the US.
The stable outlooks reflect AM Best’s expectation that Nissay will maintain its overall balance sheet assessment, supported by its risk-adjusted capitalisation at the strongest level, as measured by BCAR.
Ongoing strategic initiatives by management also are expected to ensure Nissay maintains a stable operating performance over the intermediate term.
- January 18, 2021
- Comment (1861)
- Trackback(0)
Comment(s) Write comment
cialis no prescription overnight delivery <a href="https://qcialiuss.com/ ">tadalafil sublingual</a> cialis kaufen mit paypal zahlen https://qcialiuss.com/
-
Jrnogaima Web Site
- August 11, 2022
cialis over the counter usa <a href="https://pocialgo.com/ ">overnight cialis delivery</a> cialis from india online pharmacy https://pocialgo.com/
-
Ntcegaima Web Site
- August 11, 2022
cheap cialis generic <a href="https://formenciales.com/ ">no prescription female cialis</a> tadalafil laundry detergent
-
AfgoAmows Web Site
- August 10, 2022
doxycycline for malaria <a href="http://doxycyclineus.com/#">buy doxycycline hyclate 100mg without a rx </a> doxycycline hyclate and birth control how long does it take for doxycycline to leave your system
-
plaquenil 150 mg Web Site
- August 9, 2022
amoxicillin and advil [url=https://amoxilus.com/#]amoxicillin drug [/url] does amoxicillin taking farmapram and amoxil together
-
doxycycline 100 mg pill Web Site
- August 8, 2022
pictures of penis on cialis <a href="https://tocialius.com/ ">online farmacy cialis</a> cialis shop in australia
-
JunbNulajagma Web Site
- August 8, 2022
enhanced athlete nolvadex <a href="https://nolvadexusa.com/#">cost of tamoxifen tablets </a> dallas gynecomastia "nolvadex" how to find nolvadex
-
revia average cost Web Site
- August 7, 2022
plaquenil allergic reaction [url=http://plaquenilus.com/#]plaquenil toxicity symptoms [/url] does plaquenil lower blood pressure what medicine should be taken with plaquenil
-
goodrx viagra Web Site
- August 6, 2022
can you buy generic viagra uk <a href="https://seinviagro.com/ ">viagra uk where to buy</a> discount viagra
-
Jrvxgaima Web Site
- August 5, 2022
viagra from canadian online pharmacies <a href="https://zpharz.com/ ">canadian pharmacy store rating/safety</a> safe canadian pharmacy online
-
Nrfxgaima Web Site
- August 5, 2022
cialis generic viagra <a href="https://liviagrdo.com/ ">viagra 200mg tablets</a> cheapest sildenafil tablets
-
WrfvBries Web Site
- August 5, 2022
prescription drugs info <a href="https://upharmu.com/ ">canadian pharmacy insulin</a> precision rx pharmacy
-
Egwsaisa Web Site
- August 5, 2022
buy 90 sildenafil 100mg price <a href="https://tabviagrleo.com/ ">cheap generic sildenafil</a> viagra generic from india
-
Jikagaima Web Site
- August 5, 2022
amoxicillin-clavulanate <a href="https://amoxilus.com/#">order amoxicillin uk </a> amoxicillin sulfa amoxil to treat strep pharyngitis
-
nolvadex 40mg Web Site
- August 4, 2022
JxedNulajagma Web Site- August 14, 2022